|
DYRK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.090400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.205600E-01 |
| Normal-vs-Stage2 |
3.871400E-01 |
| Normal-vs-Stage3 |
6.586000E-01 |
| Normal-vs-Stage4 |
2.928200E-01 |
| Stage1-vs-Stage2 |
3.345200E-01 |
| Stage1-vs-Stage3 |
6.354200E-01 |
| Stage1-vs-Stage4 |
2.384200E-01 |
| Stage2-vs-Stage3 |
5.811200E-01 |
| Stage2-vs-Stage4 |
9.869200E-01 |
| Stage3-vs-Stage4 |
5.473000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.205200E-01 |
| Normal-vs-AfricanAmerican |
6.662400E-01 |
| Normal-vs-Asian |
5.550400E-01 |
| Caucasian-vs-AfricanAmerican |
5.537200E-01 |
| Caucasian-vs-Asian |
3.873600E-01 |
| AfricanAmerican-vs-Asian |
9.625200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.704400E-01 |
| Normal-vs-Female |
9.069000E-01 |
| Male-vs-Female |
1.453220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.013400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.514600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.882600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.161400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.711200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.572840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.444800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.443600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.684200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.335600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.319600E-01 |
| Classical-VS-Follicular |
5.61610002947077E-09 |
| Classical-VS-Other |
1.306600E-01 |
| Classical-VS-Normal |
3.333000E-01 |
| Tall-VS-Follicular |
1.492480E-02 |
| Tall-VS-Other |
3.472000E-01 |
| Tall-VS-Normal |
8.537800E-01 |
| Follicular-VS-Other |
6.871200E-01 |
| Follicular-VS-Normal |
1.476700E-03 |
| Other-VS-Normal |
2.463000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.687800E-01 |
| Normal-vs-N1 |
2.816200E-01 |
| N0-vs-N1 |
8.045800E-01 |
|
|
